| scholarly article | Q13442814 |
| P356 | DOI | 10.7164/ANTIBIOTICS.52.374 |
| P953 | full work available at URL | https://www.jstage.jst.go.jp/article/antibiotics1968/52/4/52_4_374/_pdf |
| P698 | PubMed publication ID | 10395273 |
| P5875 | ResearchGate publication ID | 12904542 |
| P7228 | access restriction status | open access | Q232932 |
| P2093 | author name string | A Markus | |
| J Wink | |||
| L Vértesy | |||
| M Knauf | |||
| M Vogel | |||
| W Aretz | |||
| P2860 | cites work | A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules | Q29616473 |
| Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins | Q29616474 | ||
| Improved spectral resolution in cosy 1H NMR spectra of proteins via double quantum filtering | Q29618846 | ||
| Novel retrovirus protease inhibitors, RPI-856 A, B, C and D, produced by Streptomyces sp. AL-322. | Q42283638 | ||
| Mer-N5075A, a potential HIV-1 protease inhibitor, produced by Streptomyces chromofuscus. | Q42286724 | ||
| Chloropeptins, new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp. I. Taxonomy, fermentation, isolation, and physico-chemical properties and biological activities. | Q42550839 | ||
| FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2',3'-dideoxynucleosides | Q42552437 | ||
| Siamycins I and II, new anti-HIV peptides: I. Fermentation, isolation, biological activity and initial characterization. | Q42564610 | ||
| Complestatin, a potent anti-complement substance produced by Streptomyces lavendulae. I. Fermentation, isolation and biological characterization | Q69964405 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | H-nTyr-Phg(3,5-diOH)-D-Val-Phg(3,5-diOH)-D-nTyr-Phg(3,5-diOH)-D-nTyr-Phg(3,5-diOH)-D-Val-Phg(3,5-diOH)-D-nTyr-D-Phe-D-Asp-OH | Q105222821 |
| H-D-nTyr-D-Phg(3,5-diOH)-Val-D-Phg(3,5-diOH)-nTyr-D-Phg(3,5-diOH)-nTyr-D-Phg(3,5-diOH)-Val-D-Phg(3,5-diOH)-nTyr-Phe-Asp-OH | Q110187783 | ||
| Streptomyces | Q1144013 | ||
| P6954 | online access status | open access | Q232932 |
| P304 | page(s) | 374-82 | |
| P577 | publication date | 1999-01-01 | |
| 1999-04-01 | |||
| P1433 | published in | The Journal of Antibiotics | Q7743552 |
| P1476 | title | Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation | |
| P478 | volume | 52 |
| Q91816984 | A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance |
| Q37112508 | Advances in MRSA drug discovery: where are we and where do we need to be? |
| Q46453851 | Alanine scan of the peptide antibiotic feglymycin: assessment of amino acid side chains contributing to antimicrobial activity |
| Q89464393 | Antibacterial Agents Targeting the Bacterial Cell Wall |
| Q40444108 | Bioactivity of topologically confined gramicidin A dimers. |
| Q34392391 | Biosynthesis and mode of action of lantibiotics. |
| Q52861046 | Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism. |
| Q38137920 | Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials |
| Q39302851 | Design, synthesis and functional analysis of dansylated polytheonamide mimic: an artificial peptide ion channel. |
| Q33752179 | Enantioselective Synthesis of α-Bromonitroalkanes for Umpolung Amide Synthesis: Preparation of tert-Butyl ((1R)-1-(4-(benzyloxy)phenyl)-2-bromo-2-nitroethyl)carbamate |
| Q33507119 | Engineering a beta-helical D,L-peptide for folding in polar media |
| Q52895876 | Feglymycin is an inhibitor of the enzymes MurA and MurC of the peptidoglycan biosynthesis pathway. |
| Q39283283 | Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120. |
| Q48262869 | Genome-based classification of micromonosporae with a focus on their biotechnological and ecological potential |
| Q34433222 | Heterologous production of the lantibiotic Ala(0)actagardine in Escherichia coli |
| Q45894002 | In Situ-Generated Glycinyl Chloroaminals for a One-Pot Synthesis of Non-proteinogenic α-Amino Esters. |
| Q85494582 | Isolation and characterization of NAI-802, a new lantibiotic produced by two different Actinoplanes strains |
| Q39137012 | Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review |
| Q27640413 | NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity |
| Q38172657 | New antibacterial agents: patent applications published in 2011. |
| Q113959262 | Nocathioamides, Uncovered by a Tunable Metabologenomic Approach, Define a Novel Class of Chimeric Lanthipeptides |
| Q114869295 | Nocathioamides, Uncovered by a Tunable Metabologenomic Approach, Define a Novel Class of Chimeric Lanthipeptides |
| Q52846617 | On-Demand Complex Peptide Synthesis: An Aspirational (and Elusive?) Goal for Peptide Synthesis. |
| Q43772165 | Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362. |
| Q88088680 | Palladium-Catalyzed Enantioselective Three-Component Synthesis of α-Arylglycines |
| Q92773624 | Regulation of teicoplanin biosynthesis: refining the roles of tei cluster-situated regulatory genes |
| Q40759490 | Silyl imine electrophiles in enantioselective catalysis: a Rosetta Stone for peptide homologation, enabling diverse N-protected aryl glycines from aldehydes in three steps |
| Q38458869 | Structural aspects of phenylglycines, their biosynthesis and occurrence in peptide natural products. |
| Q58455863 | The Case of Lipid II: The Achilles’ Heel of Bacteria |
| Q81327478 | The antiviral antibiotic feglymycin: first direct-methods solution of a 1000+ equal-atom structure |
| Q41826662 | Total synthesis of feglymycin based on a linear/convergent hybrid approach using micro-flow amide bond formation. |
| Q39889462 | Total synthesis of the antiviral peptide antibiotic feglymycin |
| Q59383661 | Totalsynthese des antiviralen Peptidantibiotikums Feglymycin |
Search more.